Correction to: A Multi-center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency.

Santamaria, Manuel; Neth, Olaf; Douglass, Jo A; Krivan, Gergely; Kobbe, Robin; Bernatowska, Ewa; Grigoriadou, Sofia; Bethune, Claire; Chandra, Anita; Horneff, Gerd; Borte, Michael; Sonnenschein, Anja; Kralickova, Pavlina; Ramón, Silvia Sánchez; Langguth, Daman D; Gonzalez-Granado, Luis Ignacio; Alsina, Laia; Querolt, Montse; Griffin, Rhonda; Hames, Carrie; Mondou, Elsa; Price, Jeffrey; Sanz, Ana; Lin, Jiang

View / Open Files

Bibliographic metadata (XML, 23Kb)

Published version (PDF, 475Kb)

Authors

Santamaria, Manuel

Neth, Olaf

Douglass, Jo A

Krivan, Gergely

Kobbe, Robin

Bernatowska, Ewa

Grigoriadou, Sofia

Publication Date

2022-04

Journal Title

J Clin Immunol

ISSN

0271-9142

Publisher

Springer Science and Business Media LLC

Volume

Issue

Pages

512-513

Language

Type

Other

This Version

VoR

Metadata

Show full item record

Citation

Santamaria, M., Neth, O., Douglass, J. A., Krivan, G., Kobbe, R., Bernatowska, E., Grigoriadou, S., et al. (2022). Correction to: A Multi-center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency.. [Other]. https://doi.org/10.1007/s10875-022-01219-3

Keywords

Correction

Identifiers

s10875-022-01219-3, 1219

External DOI: https://doi.org/10.1007/s10875-022-01219-3

This record's DOI: https://doi.org/10.17863/CAM.83632

Rights

Licence:

http://creativecommons.org/licenses/by/4.0/

Statistics

Total file downloads (since January 2020). For more information on metrics see the IRUS guide.